Aar Shyam shareholders: Clear approval for SVR acquisition
Aar Shyam shareholders have approved the SVR acquisition, enhancing the company’s growth potential.
Aar Shyam shareholders have approved the SVR acquisition, enhancing the company’s growth potential.
RPG Life Sciences growth strategy focuses on API acquisitions to enhance market presence and drive innovation in the pharma sector.